Spotless Management

Results

111

21 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

111 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MSFT	US$451.10	18.2%	-15.4%	US$2.9t	US$561.58	25.0	14.0%	0.8%	Software
	2330	NT$2,205.00	-8.3%	90.1%	NT$57.2t	NT$3,117.26	25.8	21.2%	1.0%	Semiconductors
	A005930	₩207,000.00	-23.3%	189.9%	₩1316.6t	₩485,870.06	16.3	38.1%	1.1%	Tech
	AZN	UK£127.20	0.3%	12.3%	UK£197.3b	UK£159.11	25.4	13.8%	1.9%	Pharmaceuticals & Biotech
	SAP	€155.92	21.5%	-37.8%	€179.5b	€201.55	23.1	11.5%	1.6%	Software
	AIR New	€204.00	-0.2%	15.9%	€161.5b	€222.91	27.2	14.7%	1.6%	Capital Goods
	GILD	US$131.28	0.3%	16.9%	US$164.8b	US$157.15	17.7	20.3%	2.5%	Pharmaceuticals & Biotech
	GLW New	US$135.22	-13.4%	113.8%	US$106.9b	US$193.40	61.3	28.3%	0.8%	Tech
	CMI New	US$632.98	-4.8%	72.2%	US$83.6b	US$754.86	32.7	17.6%	1.3%	Capital Goods
	BA.	UK£20.50	4.3%	13.6%	UK£57.2b	UK£22.94	28.2	10.9%	1.8%	Capital Goods
	4519	JP¥7,071.00	-2.0%	-3.9%	JP¥11.6t	JP¥9,686.67	24.7	12.2%	1.9%	Pharmaceuticals & Biotech
	RHM	€1,139.60	12.1%	-34.3%	€53.0b	€1,697.85	50.5	30.6%	1.0%	Capital Goods
	HO	€243.30	2.1%	3.2%	€50.0b	€292.67	33.4	16.3%	1.6%	Capital Goods
	603259	CN¥125.48	-1.5%	30.3%	CN¥373.6b	CN¥150.47	19.6	11.1%	1.5%	Pharmaceuticals & Biotech
	ADS New	€157.15	-11.0%	-6.5%	€31.7b	€207.59	19.9	15.1%	1.8%	Consumer Durables
	STLD	US$252.47	4.9%	97.9%	US$36.2b	US$272.38	22.5	17.2%	0.8%	Materials
	600183 New	CN¥100.08	-20.0%	133.2%	CN¥243.1b	CN¥137.08	61.9	28.6%	1.6%	Tech
	EXPN	UK£28.98	9.2%	-27.6%	UK£25.6b	UK£37.15	23.0	10.0%	1.8%	Commercial Services
	992	HK$21.74	-11.7%	114.8%	HK$269.7b	HK$28.73	18.0	20.1%	1.9%	Tech
	FSR	R97.45	3.7%	25.8%	R535.3b	R105.48	12.3	15.9%	5.3%	Diversified Financials
	HAL	₹4,581.40	-0.2%	1.0%	₹3.1t	₹5,165.96	33.6	12.3%	1.0%	Capital Goods
	BAP New	US$402.27	3.8%	69.7%	US$30.5b	US$404.47	2.7	13.1%	3.7%	Banks
	500049 New	₹384.80	-5.1%	0.5%	₹2.8t	₹489.61	45.8	14.2%	0.6%	Capital Goods
	2327	NT$456.50	-34.4%	244.5%	NT$938.7b	NT$1,110.38	36.0	26.7%	1.3%	Tech

Page 1 of 4